SCImago Journal & Country Rank

Ranking and Indexing

Rank:
Index Copernicus Value (2010): 5.45
CNCSIS B+ (code 820) since 2007

International Databases:
SCOPUS since 2009
EBSCO Academic Search Complete since 2008
Index Copernicus Journals Master List since 2009
Directory of Open Access Journals (DOAJ) since 2008
ProQuest
Genamics JournalSeek since 18/2008

International Catalogues:
Oxford University's Library since 2003

Journal Info

Title: Studia Universitatis Vasile Goldis, Seria Stiintele Vietii (Life Sciences Series)
Abbreviated title: Studia Univ. VG, SSV
Publisher: "Vasile Goldis" University Press
Owner: Western University "Vasile Goldis" Arad, Romania
ISSN: 1584-2363
e-ISSN: 1842-7863
ISSN-L: 1584-2363

Who's Online

We have 95 guests online

Index Databases

Increasing the bioavalilability of mebendazole II. Influence of Croscarmellose on dissolution rate, extent and mechanism in simulated intestinal medium Print E-mail
Written by Ghafil F., Anuta V., Sarbu I.,Toderescu C.D., Mircioiu I.   

Read full article
Article Title: Increasing the bioavalilability of mebendazole II. Influence of Croscarmellose on dissolution rate, extent and mechanism in simulated intestinal medium
Authors: Ghafil F., Anuta V., Sarbu I.,Toderescu C.D., Mircioiu I.
Affiliation: 2 1 Ministry of Health-Iraq Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia, Bucharest, Romania 3 Faculty of Pharmacy, “Titu Maiorescu“ University, Bucharest, Romania

Abstract: ABSTRACT: Objective of the research was the developing of tablets with increased rate and extent of release of mebendazole in intestine in order to improve its bioavailability and pharmacokinetic profile. Three solid formulations containing 1%, 2% and 3 % croscarmellose sodium, with superdisintegrant properties were prepared. For the quantitative assay of mebendazole a HPLC-UV method was developed and validated. Bioavailability was estimated by means of the in-vitro release kinetics using USP Apparatus 2, in Fasting State Simulated Intestinal Fluid (FaSSIF). Release of mebendazole in FaSSIF was poor (less than 10 % within 2 hours). Dissolution could be described by Higuchi law and Peppas law in both the swelling phase and post-errosion-disintegration phase, suggesting a diffusion controlled release. Both rate and extent of release increased with concentration of croscarmellose predicting a better bioavailability of mebendazole from the croscarmellose containing tablets.
Keywords: mebendazole, croscarmellose, in vitro release, FaSSIF, intestinal suprasaturation
*Correspondence: Valentina Anuta, “Carol Davila” University of Medicine and Pharmacy, Faculty of Pharmacy, 6 Traian Vuia Street, Bucharest, Romania, email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it